The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Mechanisms of switching on p53: a role for covalent modification?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 1×
“This induction is dependent on a product of the INK4A tumour suppressor gene which encodes two unrelated proteins, p16INK4A and p19ARF (murine protein) or p14ARF (human protein) (Quelle et al., 1995; Serrano et al., 1993).”
BackgroundRegulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“…to a region of the transactivation domain (Oliner et al., 1993; Zauberman et al., 1993) and mediates rapid turnover of p53 by targeting it to the 26S proteosome through a mechanism involving MDM2-mediated ubiquitination of p53 (Haupt et al., 1997; Honda and Yasuda, 1999; Kubbutat et al., 1997).”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“ATM had long been suspected of being an upstream component of the p53 pathway on the basis that the induction of p53 in cells from AT patients showed a signi®cant delay in the response to IR (Kastan et al., 1992; Khanna and Lavin, 1993).”
BackgroundDNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100 · cited 4×
“Details of these modi®cations are given in the text phosphorylation in MDM2 binding and in promoting C-terminal modi®cation by acetylation (Sakaguchi et al., 1998; Shieh et al., 1997).”
BackgroundInfluentialActivation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521 · cited 3×
“These increased levels of p53 are re¯ected in the induction of p53-dependent transcription, growth arrest, apoptosis and suppression of oncogenic transformation (Pomerantz et al., 1998; Stott et al., 1998; Zhang et al., 1998).”
BackgroundOuelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
mdm2 expression is induced by wild type p53 activity.
Barak, Y., Juven, T., Haffner, R., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05678.x · Cited by 1,290
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
DNA damage activates p53 through a phosphorylation–acetylation cascade
Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., & Appella, E. (1998) · Genes & Development · doi:10.1101/gad.12.18.2831 · Cited by 1,204 · cited 7×
“Moreover, the enhanced phosphorylation of serine 37 by UV as compared with IR is consistent with a major role for ATR after UV-induction (Sakaguchi et al., 1998).”
BackgroundInfluentialA role for ATR in the DNA damage-induced phosphorylation of p53
Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Shieh, S.-Y., Taya, Y., Prives, C., & Abraham, R. T. (1999) · Genes & Development · doi:10.1101/gad.13.2.152 · Cited by 1,046 · cited 15×
“While recent progress has provided strong evidence for the role of ATM and ATR in the induction process, little is known at present concerning the protein kinase or phosphatase activities which modify these other sites during the response.”
BackgroundInfluentialLin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.19.3008 · Cited by 945
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., & Sherr, C. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8292 · Cited by 899
DNA damage induces phosphorylation of the amino terminus of p53
Siliciano, J. D., Canman, C. E., Taya, Y., Sakaguchi, K., Appella, E., & Kastan, M. B. (1997) · Genes & Development · doi:10.1101/gad.11.24.3471 · Cited by 818 · cited 3×
“Phosphopeptide mapping indicated that phosphorylation events additional to serine 15 modi®cation also occurred at the N-terminus of p53 (Siliciano et al., 1997).”
BackgroundInfluentialp53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage
Liu, L., Scolnick, D. M., Trievel, R. C., Zhang, H. B., Marmorstein, R., Halazonetis, T. D., & Berger, S. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1202 · Cited by 776
Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
Honda, R., & Yasuda, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.22 · Cited by 724
Regulation of p53 function and stability by phosphorylation.
Ashcroft, M., Kubbutat, M. H. G., & Vousden, K. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1751 · Cited by 452
Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo
Böttger, A., Böttger, V., Sparks, A., Liu, W.-L., Howard, S. F., & Lane, D. P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00374-5 · Cited by 363 · cited 1×
“…of the interaction between endogenous p53 and MDM2 proteins in cells expressing only wild type p53 is su cient in itself to stabilize the p53 and elicit a measurable p53 response in terms of activation of a p53-responsive reporter gene and the onset of cell cycle arrest (Bottger et al., 1997).”
BackgroundWright, J. A., Keegan, K. S., Herendeen, D. R., Bentley, N. J., Carr, A. M., Hoekstra, M. F., & Concannon, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7445 · Cited by 226
Comparative study of the p53-mdm2 and p53-MDMX interfaces
Böttger, V., Böttger, A., Garcia-Echeverria, C., Ramos, Y. F., van der Eb, A. J., Jochemsen, A. G., & Lane, D. P. (1999) · Oncogene · doi:10.1038/sj.onc.1202281 · Cited by 189 · cited 2×
“For example, although in vitro evidence suggests a possible role for threonine 18 in regulating MDM2 binding (Bottger et al., 1999), a threonine 18 kinase has not yet been reported.”
Background
Research works printed but not linked: 57
- Abraham J, Spaner D and Benchimol S. . 1999 Oncogene 18: 1521–1527. · DOI
- Adler V, Pincus MR, Minamoto T, Fuchs SY, Bluth MJ, Brandt-Rauf PW, Friedman FK, Robinson RC, Chen JM, Wang XW, Harris CC and Ronai Z. . 1997 Proc. Natl. Acad. Sci. USA 94: 1686–1691. · DOI
- Agarwal ML, Taylor WR, Chernov MV, Chernova OB and Stark GR. . 1998 J. Biol. Chem. 273: 1–4. · DOI · Paper page
- Anderson CW. . 1994 Semin. Cell Biol. 5: 427–436. · DOI
- Anderson ME, Woelker B, Reed M, Wang P and Tegtmeyer P. . 1997 Mol. Cell. Biol. 17: 6255–6264. · DOI
- Banin S, Moyal L, Shieh S-Y, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y and Ziv Y. . 1998 Science 281: 1674–1677. · DOI · Paper page
- Baudier J, Delphin C, Grunwald D, Khochbin S and Lawrence JJ. . 1992 Proc. Natl. Acad. Sci. USA 89: 11627–11631. · DOI · Paper page
- Blattner C, Tobiasch E, Litfen M, Rahmsdorf HJ and Herrlich P. . 1999 Oncogene 18: 1723–1732. · DOI · Paper page
- Blaydes JP and Hupp TR. . 1998 Oncogene 17: 1045–1052. · DOI
- Chernov MV, Ramana CV, Adler VA and Stark GR. . 1998 Proc. Natl. Acad. Sci. USA 95: 2284–2289. · DOI
- Cliby WA, Roberts CJ, Cimprich KA, Stringer CM, Lamb JR, Schreiber SL and Friend SH. . 1998 EMBO J. 17: 159–169. · DOI · Paper page
- de Stanchina E, McCurrach ME, Zindy F, Shieh S-Y, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ and Lowe SW. . 1998 Genes Dev. 12: 2434–2442. · DOI · Paper page
- Delphin C and Baudier J. . 1994 J. Biol. Chem. 269: 29579–29587. · DOI
- Fried LM, Koumenis C, Peterson SR, Green SL, van Zijl P, Allalunis TJ, Chen DJ, Fishel R, Giaccia AJ, Brown JM and Kirchgessner CU. . 1996 Proc. Natl. Acad. Sci. USA 93: 13825–13830. · DOI
- Fuchs SY, Adler V, Buschmann T, Yin Z, Wu X, Jones SN and Ronai Z. . 1998a Genes Dev. 12: 2658–2663. · DOI · Paper page
- Fuchs SY, Adler V, Pincus MR and Ronai Z. . 1998b Proc. Natl. Acad. Sci. USA 95: 10541–10546. · DOI · Paper page
- Fukasawa K, Wiener F, Vande Woude GF and Mai S. . 1997 Oncogene 15: 1295–1302. · DOI · Paper page
- Giaccia AJ and Kastan MB. . 1998 Genes Dev. 12: 2973–2983. · DOI · Paper page
- Gu W and Roeder RG. . 1997 Cell 90: 595–606. · DOI · Paper page
- Guidos CJ, Williams CJ, Grandal I, Knowles G, Huang MTF and Danska JS. . 1996 Genes Dev. 10: 2038–2054. · DOI · Paper page
- Hao M, Lowy AM, Kapoor M, Deffie A, Liu G and Lozano G. . 1996 J. Biol. Chem. 271: 29380–29385. · DOI
- Hu MC-T, Qui WR and Wang Y-P. . 1997 Oncogene 15: 2277–2287. · DOI
- Hupp TR and Lane DP. . 1994 Cold Spring Harbor Symp. Quant. Biol. 59: 195–206. · DOI
- Hupp TR, Meek DW, Midgley CA and Lane DP. . 1992 Cell 71: 875–886. · DOI · Paper page
- Jackson SP and Jeggo PA. . 1995 Trends Biochem. Sci. 20: 412–415. · DOI · Paper page
- Kapoor M and Lozano G. . 1998 Proc. Natl. Acad. Sci. USA 95: 2834–2837. · DOI · Paper page
- Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, Hobson K, Taya Y, Gabrielli B, Chan D, Lees-Miller SP and Lavin MF. . 1998 Nature Genet. 20: 398–400. · DOI · Paper page
- Knippschild U, Milne DM, Campbell LE, DeMaggio AJ, Christenson E, Hoekstra MF and Meek DW. . 1997 Oncogene 15: 1727–1736. · DOI · Paper page
- Ko LJ, Shieh S-Y, Chen X, Jayaraman L, Tamai K, Taya Y, Prives C and Pan Z-Q. . 1997 Mol. Cell. Biol. 17: 7220–7229. · DOI · Paper page
- Lambert PF, Kashanchi F, Radonovich MF, Shiekhattar R and Brady JN. . 1998 J. Biol. Chem. 273: 33048–33053. · DOI · Paper page
- Lees MS, Sakaguchi K, Ullrich SJ, Appella E and Anderson CW. . 1992 Mol. Cell. Biol. 12: 5041–5049. · doi:10.1128/mcb.12.11.5041-5049.1992 · Paper page
- Lees-Miller SP, Chen Y-R and Anderson CW. . 1990 Mol. Cell. Biol. 10: 6472–6481. · doi:10.1128/mcb.10.12.6472-6481.1990 · Paper page
- Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsty TD. . 1992 Cell 70: 923–935. · DOI · Paper page
- Lu H, Fisher RP, Bailey P and Levine AJ. . 1997 Mol. Cell. Biol. 17: 5923–5934. · DOI
- Lu H, Taya Y, Ikeda M and Levine AJ. . 1998 Proc. Natl. Acad. Sci. USA 95: 6399–6402. · DOI · Paper page
- Meek DW. . 1997 Pathol. Biol. 45: 804–814. · doi:10.18267/j.polek.307
- Meek DW. . 1998 Cell. Signal. 10: 159–166. · doi:10.1023/a:1022023600714
- Meek DW, Simon S, Kikkawa U and Eckhart W. . 1990 EMBO J. 9: 3253–3260. · DOI · Paper page
- Milne DM, Campbell DG, Caudwell FB and Meek DW. . 1994 J. Biol. Chem. 269: 9253–9260. · DOI
- Milne DM, Campbell L, Campbell DG and Meek DW. . 1995 J. Biol. Chem. 270: 5511–5518. · DOI · Paper page
- Mundt M, Hupp T, Fritsche M, Merkle C, Hansen S, Lane D and Groner B. . 1997 Oncogene 15: 237–244. · DOI
- Nacht M, Strasser A, Chan YR, Harris AW, Schlissel M, Bronson RT and Jacks T. . 1996 Genes Dev. 10: 2055–2066. · DOI · Paper page
- Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein B. . 1993 Nature 362: 857–860. · DOI · Paper page
- Palmero I, Pantoja C and Serrano M. . 1998 Nature 395: 125–126. · DOI · Paper page
- Pise-Masison CA, Radonovich M, Sakaguchi K, Appella E and Brady JN. . 1998 J. Virol. 72: 6348–6355. · DOI
- Prives C and Hall PA. . 1999 J. Path. 187: 112–126. · doi:10.1002/(sici)1096-9896(199901)187:1<112::aid-path250>3.0.co;2-3
- Sakaguchi K, Sakamoto M, Lewis MS, Anderson CW, Erikson JW, Appella E and Xie D. . 1997 Biochemistry 36: 10117–10124. · DOI · Paper page
- Shieh S-Y, Taya Y and Prives C. . 1999 EMBO J. 18: 1815–1823. · DOI · Paper page
- Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH and Peters G. . 1998 EMBO J. 17: 5001–5014. · DOI · Paper page
- Takenaka I, Morin F, Seizinger BR and Kley N. . 1995 J. Biol. Chem. 270: 5405–5411. · DOI · Paper page
- Wang Y and Prives C. . 1995 Nature 376: 88–91. · DOI · Paper page
- Waterman MJF, Stavridi ES, Waterman JLF and Halazonetis TD. . 1998 Nature Genet. 19: 175–178. · DOI · Paper page
- Watters D, Khanna KK, Beamish H, Birrell G, Spring K, Kedar P, Gatei M, Stenzel D, Hobson K, Kozlov S, Zhang N, Farrell A, Ramsay J, Gatti R and Lavin M. . 1997 Oncogene 14: 1911–1921. · DOI · Paper page
- Woo RA, McLure KG, Lees-Miller SP, Rancourt DE and Lee PWK. . 1998 Nature 394: 700–704. · DOI · Paper page
- Yin Y, Tainsky MA, Bischoff FZ, Strong LC and Wahl GM. . 1992 Cell 70: 937–948. · DOI · Paper page
- Zauberman A, Barak Y, Ragimov N, Levy N and Oren M. . 1993 EMBO J. 12: 2799–2808. · DOI
- Zauberman A, Flusberg D, Haupt Y, Barak Y and Oren M. . 1995 Nucl. Acids Res. 23: 2584–2592. · DOI · Paper page
Cited by
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Fridman, J. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1207116 · Cited by 1,401
“The most well-studied p53 modification is phosphorylation, and indeed p53 can be phosphorylated on many residues (see, for review, Meek, 1999; Prives and Hall, 1999).”
BackgroundRubbi, C. P. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg579 · Cited by 811
Defying death after DNA damage
Rich, T., Allen, R. L., & Wyllie, A. H. (2000) · Nature · doi:10.1038/35037717 · Cited by 724
Metadata
- Authors
- Meek, D. W.
- Venue
- Oncogene
- Published
- 1999-12-13
- Volume
- 18
- Issue
- 53
- Pages
- 7666-7675
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1974836748
- Cited by
- 236
- References
- 25
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.